Asahi Kasei Therapeutics

Beyond's analysis on Asahi Kasei Therapeutics

• 2026-09-14 — Basilea’s partner Asahi Kasei Therapeutics starts a pediatric clinical trial in Japan for the antifungal Cresemba, widening the drug’s potential patient base

Recent news mentioning Asahi Kasei Therapeutics

• 2026-09-14 — Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
• 2026-09-14 — Basileas Partner Asahi Kasei Therapeutics startet klinische Studie mit Antipilzmittel Cresemba® (Isavuconazol) bei Kindern in Japan

Appears alongside

• Japan
• Cresemba

Browse the full archive →